NCT02761252View on ClinicalTrials.gov

Efficacy of Co-administration of Bilastine and Montelukast in Patients With SARC and Asthma

PHASE4CompletedINTERVENTIONAL

Enrollment

454

Participants

Timeline

Start Date

April 13, 2016

Primary Completion Date

November 24, 2016

Study Completion Date

November 24, 2016

Conditions

Seasonal Allergic RhinoconjunctivitisAsthma

Interventions

DRUG

Bilastine 20mg

DRUG

Montelukast 10mg

DRUG

Placebo Bilastine 20mg

DRUG

Placebo Montelukast 10mg

Trial Locations (32)

Unknown

Čakovec

Rijeka

Zagreb

Brno

Ostrava Hrabuvka

Teplice

Dreieich

Heidelberg

Catania

Florence

Modena

Pavia

Verona

Riga

Bialystok

Bielsko-Biala

Gdansk

Katowice

Krakow

Lodz

Lublin

Nowy Duninów

Poznan

Rzeszów

Tarnów

Wroclaw

Brasov

Bucharest

Cluj-Napoca

Ploieşti

Bardejov

Levice

All Listed Sponsors

lead

Menarini International Operations Luxembourg SA

INDUSTRY

NCT02761252 - Efficacy of Co-administration of Bilastine and Montelukast in Patients With SARC and Asthma | Biotech Hunter | Biotech Hunter